Page last updated: 2024-08-23

raloxifene hydrochloride and Adjuvant Arthritis

raloxifene hydrochloride has been researched along with Adjuvant Arthritis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Enokida, M; Hagino, H; Hayashi, I; Okano, T; Teshima, R1
Carlsten, H; Engdahl, C; Erlandsson, M; Gjertsson, I; Holmdahl, R; Islander, U; Jochems, C; Lagerquist, M; Ohlsson, C1
Carlsten, H; Engdahl, C; Erlandsson, M; Holmdahl, R; Islander, U; Jochems, C; Lagerquist, M; Nandakumar, KS; Ohlsson, C1
Andersson, A; Carlsten, H; Islander, U; Jochems, C; Lagerquist, MK; Ohlsson, C; Stubelius, A1
Carlsten, H; Islander, U; Jochems, C; Kallkopf, A; Lagerquist, M; Ohlsson, C1
Carlsten, H; HÃ¥kansson, C; Jochems, C; Lagerquist, M; Ohlsson, C1

Other Studies

6 other study(ies) available for raloxifene hydrochloride and Adjuvant Arthritis

ArticleYear
Effect of raloxifene on arthritis and bone mineral density in rats with collagen-induced arthritis.
    Calcified tissue international, 2011, Volume: 88, Issue:2

    Topics: Animals; Arthritis; Arthritis, Experimental; Bone Density; Bone Density Conservation Agents; Bone Resorption; Disease Models, Animal; Female; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley

2011
Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis.
    BMC musculoskeletal disorders, 2010, Dec-16, Volume: 11

    Topics: Animals; Arthritis, Experimental; Cartilage; Disease Models, Animal; Disease Progression; Estradiol; Estrogens; Female; Interleukin-6; Mice; Mice, Inbred DBA; Mice, Mutant Strains; Mutation; NADPH Oxidases; Osteoarthritis; Ovariectomy; Prevalence; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2010
Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis.
    Clinical and experimental immunology, 2011, Volume: 165, Issue:1

    Topics: Animals; Antibodies; Arthritis, Experimental; Biomarkers; Bone Marrow; Collagen; Disease Progression; Estradiol; Female; Humans; Immunomodulation; Mice; Mice, Inbred DBA; Mice, Transgenic; Osteoporosis, Postmenopausal; Ovariectomy; Raloxifene Hydrochloride; Response Elements; Selective Estrogen Receptor Modulators; Transgenes

2011
Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis.
    Arthritis research & therapy, 2011, Jun-20, Volume: 13, Issue:3

    Topics: Animals; Arthritis, Experimental; B-Lymphocytes; Bone Density; Bone Marrow; Dexamethasone; Drug Therapy, Combination; Estradiol; Estrogens; Female; Glucocorticoids; Joints; Mice; Mice, Inbred DBA; Osteoporosis; Ovariectomy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; T-Lymphocytes

2011
Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:10

    Topics: Animals; Arthritis; Arthritis, Experimental; Bone Density; Cytokines; Female; Humans; Mice; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Thiophenes; Treatment Outcome; Tumor Necrosis Factor-alpha

2007
Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis.
    Clinical and experimental immunology, 2008, Volume: 152, Issue:3

    Topics: Animals; Arthritis, Experimental; Biomarkers; Bone Density; Bone Density Conservation Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Interleukin-6; Mice; Osteoporosis, Postmenopausal; Ovariectomy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Severity of Illness Index; Treatment Outcome

2008